ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2024, Feed-forward stimulation of CAMK2 by the oncogenic pseudokinase PEAK1 generates a therapeutically 'actionable' signalling axis in triple negative breast cancer., , http://dx.doi.org/10.1101/2024.02.14.580406
,2024, Mepolizumab decreases tissue eosinophils while increasing type-2 cytokines in eosinophilic chronic rhinosinusitis, , http://dx.doi.org/10.22541/au.170669863.35814827/v1
,2022, Exercise-induced modulation of the immune microenvironment in pre-clinical breast cancer models., , http://dx.doi.org/10.21203/rs.3.rs-1789675/v1
,2019, Mechanism of preferential complex formation by Apoptosis Signal-regulating Kinases, , http://dx.doi.org/10.1101/693663
,2019, Dynamic analysis of pulsed cisplatin identifies effectors of resistance in lung adenocarcinoma, , http://dx.doi.org/10.1101/775924
,